Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Machado–Joseph disease (MJD) is a neurodegenerative disorder characterized by an abnormal expansion of the CAG triplet in the ATXN3 gene, translating into a polyglutamine tract within the ataxin-3 protein. The available treatments only ameliorate symptomatology and do not block disease progression. In this study we find that caloric restriction dramatically rescues the motor incoordination, imbalance and the associated neuropathology in transgenic MJD mice. We further show that caloric restriction rescues SIRT1 levels in transgenic MJD mice, whereas silencing SIRT1 is sufficient to prevent the beneficial effects on MJD pathology. In addition, the re-establishment of SIRT1 levels in MJD mouse model, through the gene delivery approach, significantly ameliorates neuropathology, reducing neuroinflammation and activating autophagy. Furthermore, the pharmacological activation of SIRT1 with resveratrol significantly reduces motor incoordination of MJD mice. The pharmacological SIRT1 activation could provide important benefits to treat MJD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several lines of evidence have shown that SIRT1 level is increased by DR in multiple brain regions, including hypothalamus, hippocampus, and cortex [103,104,161,162].”
From Dietary Restriction and Neuroinflammation: A Potential Mechanistic Link (2019) · cites this paper as [161]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
The Effect of Retarded Growth Upon the Length of Life Span and Upon the Ultimate Body Size
McCay, C. M., Crowell, M. F., & Maynard, L. A. (1935) · The Journal of Nutrition · doi:10.1093/jn/10.1.63 · Cited by 2,264
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Self-citationCalorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase
Cohen, H. Y., Miller, C., Bitterman, K. J., Wall, N. R., Hekking, B., Kessler, B., Howitz, K. T., Gorospe, M., de Cabo, R., & Sinclair, D. A. (2004) · Science · doi:10.1126/science.1099196 · Cited by 1,924
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1
Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I., et al. (1994) · Nature Genetics · doi:10.1038/ng1194-221 · Cited by 1,753 · cited 2×
“Interestingly, we made the following observations: (1) as expected, when autophagy is not disrupted, SIRT1 activates autophagy, demonstrated by the increase in LCBII levels and the decrease in p62; (2) SIRT1 induces mutant ataxin-3 clearance and to do this its deacetylase activity is crucial, because its inactive form…”
MethodResultA role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy
Lee, I. H., Cao, L., Mostoslavsky, R., Lombard, D. B., Liu, J., Bruns, N. E., Tsokos, M., Alt, F. W., & Finkel, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712145105 · Cited by 1,476
Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., & Horikawa, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0033 · Cited by 1,364
Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study
Mattison, J. A., Roth, G. S., Beasley, T. M., Tilmont, E. M., Handy, A. M., Herbert, R. L., Longo, D. L., Allison, D. B., Young, J. E., Bryant, M., et al. (2012) · Nature · doi:10.1038/nature11432 · Cited by 1,145
The sirtuin SIRT6 regulates lifespan in male mice
Kanfi, Y., Naiman, S., Amir, G., Peshti, V., Zinman, G., Nahum, L., Bar-Joseph, Z., & Cohen, H. Y. (2012) · Nature · doi:10.1038/nature10815 · Cited by 1,059
Cited by
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Menzies, F. M., Fleming, A., Caricasole, A., Bento, C. F., Andrews, S. P., Ashkenazi, A., Füllgrabe, J., Jackson, A., Jimenez Sanchez, M., Karabiyik, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.022 · Cited by 1,134
“A transgenic mouse model of SCA3 showed low levels of sirtuin 1 (Cunha-Santos et al., 2016), an enzyme that normally deacetylates several autophagy proteins to promote autophagy (Huang et al., 2015; Lee et al., 2008).”
Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure
Wang, Y., Xu, E., Musich, P. R., & Lin, F. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13116 · Cited by 294
Pohl, F., & Kong Thoo Lin, P. (2018) · Molecules · doi:10.3390/molecules23123283 · Cited by 272
“For example, in a SCA-3 (Machado-Joseph disease, MJD) mouse model, resveratrol activates the histone deacetylase enzyme SIRT1 pathway, showing improvement in motor behavior when treating animals at a post-symptomatic stage of disease development.”
BackgroundMethodInfluentialGene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
Saraiva, J., Nobre, R. J., & Pereira de Almeida, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.09.011 · Cited by 201
Tolahunase, M. R., Sagar, R., Faiq, M., & Dada, R. (2018) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-170810 · Cited by 167
Matos, C. A., de Almeida, L. P., & Nóbrega, C. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14541 · Cited by 171
“The effect of caloric restriction seemed to be mediated by an increase in SIRT1 levels, and, concordantly, over-expression of SIRT1 mitigated neuropathological abnormalities in a lentiviral MJD/SCA3 mouse model (Cunha-Santos et al. 2016).”
BackgroundInfluentialGenetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
Buijsen, R. A. M., Toonen, L. J. A., Gardiner, S. L., & van Roon‐Mom, W. (2019) · Neurotherapeutics · doi:10.1007/s13311-018-00696-y · Cited by 151
Key Signaling Pathways in Aging and Potential Interventions for Healthy Aging
Yu, M., Zhang, H., Wang, B. Z., Zhang, Y., Zheng, X., Shao, B., Zhuge, Q., & Jin, K. (2021) · Cells · doi:10.3390/cells10030660 · Cited by 131
“CR alleviated neuropathy and motor deficits through the SIRT1 pathway in MJD mice [46].”
BackgroundInfluentialRakshe, P. S., Dutta, B. J., Chib, S., Maurya, N., & Singh, S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102255 · Cited by 111
Wang, X., Zhang, Q., Bao, R., Zhang, N., Wang, Y., Polo‐Parada, L., Tarim, A. O., Alemifar, A., Han, X., Wilkins, H., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.022 · Cited by 93
“It is possible to reconcile these findings, as reactive gliosis can be triggered in response to mild injuries that do not cause neuronal death (Choudhury and Ding, 2016; Cunha-Santos et al., 2016; Li et al., 2014), and reactive astrogliosis could become evident before disease onset and NM death in an ALS model (Vargas…”
BackgroundNóbrega, C., Mendonça, L. S., Marcelo, A., Lamazière, A., Tomé, S. O., Després, G., Matos, C. A., Mechmet, F., Langui, D., den Dunnen, W. F. A., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02019-7 · Cited by 88
Ehrnhoefer, D. E., Martin, D. D. O., Schmidt, M. E., Qiu, X., Ladha, S., Caron, N. S., Skotte, N. H., Nguyen, Y. T. N., Vaid, K., Southwell, A. L., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0518-0 · Cited by 82
“beneficial in different neurodegenerative conditions including HD [11, 25, 26].”
BackgroundSilva, J. D. D., Teixeira‐Castro, A., & Maciel, P. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00798-1 · Cited by 82
Functional analysis of deubiquitylating enzymes in tumorigenesis and development
Cheng, J., Guo, J., North, B. J., Wang, B., Cui, C., Li, H., Tao, K., Zhang, L., & Wei, W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188312 · Cited by 84
Carmona, V., Cunha‐Santos, J., Onofre, I., Simões, A. T., Vijayakumar, U. G., Davidson, B. L., & de Almeida, L. P. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.01.021 · Cited by 73
Self-citationBeneficial effects of dietary restriction in aging brain
Hadem, I. K. H., Majaw, T., Kharbuli, B., & Sharma, R. (2019) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.10.001 · Cited by 59
“The mechanism by which DR alleviates this disorder is mediated by the upregulation of SIRT1 expression, subsequently resulting in inhibition of neuroinflammation and autophagy activation (Cunha-Santos et al., 2016).”
BackgroundFootprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria
Esteves, A. R., Muñoz, M., Nunes‐Costa, D., Candeias, E., Silva, D. F., Magalhães, J. D., Pereira-Santos, A. R., Ferreira, I. L., Alarico, S., Tiago, I., et al. (2021) · Gut · doi:10.1136/gutjnl-2021-326023 · Cited by 63
Dietary Restriction and Neuroinflammation: A Potential Mechanistic Link
Bok, E., Jo, M., Lee, S., Lee, B.-R., Kim, J., & Kim, H.-J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030464 · Cited by 53
“Several lines of evidence have shown that SIRT1 level is increased by DR in multiple brain regions, including hypothalamus, hippocampus, and cortex [103,104,161,162].”
BackgroundWu, Y., Chang, J., Lin, W., Li, C., Hsieh, M., Chen, H., Wang, T., Wu, W., Liu, C., & Liu, K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.12.011 · Cited by 53
“Res, a sirtuin1 (SIRT1) agonist, can protect against neuron cell death and improve motor performance in cell and mouse models of SCA3 [25,26].”
BackgroundCoarelli, G., Brice, A., & Dürr, A. (2018) · F1000Research · doi:10.12688/f1000research.15788.1 · Cited by 55
Caloric restriction induced epigenetic effects on aging
Zhai, J., Kongsberg, W. H., Pan, Y., Hao, C., Wang, X., & Sun, J. Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1079920 · Cited by 62
“CR was found to increase SIRT1 levels in the brains of MachadoJoseph disease (MJD) mice, significantly improve neuropathology, reduce neuroinflammation and activate autophagy (Cunha-Santos et al., 2016).”
BackgroundLobo, D. D., Nobre, R. J., Miranda, C. O., Pereira, D., Castelhano, J., Sereno, J., Koeppen, A. H., Castelo-Branco, M. S., & de Almeida, L. P. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00955-0 · Cited by 47
Sowa, A. S., Martin, E., Martins, I. M., Schmidt, J., Depping, R., Weber, J. J., Rother, F., Hartmann, E., Bäder, M., Rieß, O., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716071115 · Cited by 55
Marcelo, A., Brito, F., Carmo‐Silva, S., Matos, C. A., Alves-Cruzeiro, J., Vasconcelos‐Ferreira, A., Koppenol, R., Mendonça, L. S., de Almeida, L. P., & Nóbrega, C. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy328 · Cited by 45
Repeated Mesenchymal Stromal Cell Treatment Sustainably Alleviates Machado-Joseph Disease
Miranda, C. O., Marcelo, A., Silva, T. P., Barata, J., Vasconcelos‐Ferreira, A., Pereira, D., Nóbrega, C., Duarte, S., Barros, I., Alves, J., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.007 · Cited by 37
Mojaverrostami, S., Pasbakhsh, P., Madadi, S., Nekoonam, S., Zarini, D., Noori, L., Shiri, E., Salama, M., Zibara, K., & Kashani, I. R. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00597-0 · Cited by 40
“In contrast to our findings, few studies reported that CR decreases energy stores and reduces motor activity (Cunha-Santos et al. 2016).”
BackgroundResultChen, Y.-S., Hong, Z.-X., Lin, S., & Harn, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093063 · Cited by 39
“Caloric restriction or resveratrol rescued SIRT1 expression, induced autophagy, reduced oxidative stress, and improved motor coordination in an animal model [32].”
BackgroundInfluentialYan, P., Bai, L., Lü, W., Gao, Y., Bi, Y., & Lv, G. (2017) · PubMed Central · doi:10.22038/ijbms.2017.9272 · Cited by 34
“demonstrated that overexpression of SIRT1 provided important benefits to treat Machado-Joseph disease by regulating autophagy (28).”
BackgroundNtsapi, C., & Loos, B. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112840 · Cited by 37
Mangrulkar, S. V., Wankhede, N. L., Kale, M. B., Upaganlawar, A. B., Taksande, B. G., Umekar, M. J., Anwer, M. K., Dailah, H. G., Mohan, S., & Behl, T. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00647-2 · Cited by 36
“Comparable to CR, overexpression of SIRT1 aids in extending life and lowering illness symptoms associated with neurodegenerative disorders (Cantó and Auwerx 2009; Cunha-Santos et al. 2016).”
BackgroundTrehalose alleviates the phenotype of Machado–Joseph disease mouse models
Santana, M. M., Paixão, S., Cunha‐Santos, J., Silva, T. P., Trevino-Garcia, A., Gaspar, L. S., Nóbrega, C., Nobre, R. J., Cavadas, C., Greif, H., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02302-2 · Cited by 33
Self-citationAutophagy and lysosomal pathways in nervous system disorders
Bingol, B. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.04.009 · Cited by 34
Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease
Rippin, I., Bonder, K., Joseph, S., Sarsor, A., Vaks, L., & Eldar-Finkelman, H. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105336 · Cited by 33
“Recent studies have implicated the nuclear NAD+ dependent deacetylase Sirtuin 1 (Sirt1), as a neuroprotective agent that may compensate for deficits in motor and coordination abilities (Jiang et al., 2011; Cunha-Santos et al., 2016).”
BackgroundLee, J.-H., Lin, S.-Y., Liu, J., Lin, S., Harn, H., & Chiou, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126339 · Cited by 29
Epidrugs in the Therapy of Central Nervous System Disorders: A Way to Drive on?
Gladkova, M. G., Leidmaa, E., & Anderzhanova, E. A. (2023) · Cells · doi:10.3390/cells12111464 · Cited by 36
Li, A., Yau, S.-Y., Machado, S., Wang, P., Yuan, T.-F., & So, K.-F. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666190308102804 · Cited by 27
Gomes, P., Leal, H., Mendes, A. F., Reis, F., & Cavadas, C. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.09.003 · Cited by 28
Self-citationAntinociceptive effects of caloric restriction on post-incisional pain in nonobese rats
Liu, Y., Ni, Y., Zhang, W., Sun, Y., Ma, Z., & Gu, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-01909-8 · Cited by 27
Gene Therapies for Polyglutamine Diseases
Matos, C. A., Carmona, V., Vijayakumar, U. G., Lopes, S., Albuquerque, P., Conceição, M., Nobre, R. J., Nóbrega, C., & de Almeida, L. P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_20 · Cited by 30
Self-citationNeuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease
Duarte‐Neves, J., Cavadas, C., & de Almeida, L. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-82339-5 · Cited by 24
Self-citationPharmacological Therapies for Machado-Joseph Disease
Duarte‐Silva, S., & Maciel, P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_19 · Cited by 27
Wu, Y., Chang, J., Lin, W., Li, C., Hsieh, M., Chen, H., Wang, T., Liu, C., & Liu, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-11839-0 · Cited by 22
Wang, R., Zhou, Z., Wang, D., Zhao, Q., Zhang, C., Liu, C., Zhao, H., Yuan, C., Yuan, D., & Wang, T. (2021) · Food & Function · doi:10.1039/d0fo02946g · Cited by 22
Caloric restriction, Sirtuins, and cardiovascular diseases
Wei, Z., Yang, B., Wang, H., Lv, S., Chen, H., & Liu, D. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003056 · Cited by 23
Non-Coding RNA Molecules Connect Calorie Restriction and Lifespan
Abraham, K. J., Ostrowski, L., & Mekhail, K. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.020 · Cited by 22
Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts
Esteves, S., Duarte‐Silva, S., & Maciel, P. (2016) · Medicinal Research Reviews · doi:10.1002/med.21425 · Cited by 22
Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis
Nóbrega, C., Simões, A. T., Duarte‐Neves, J., Duarte, S., Vasconcelos‐Ferreira, A., Cunha‐Santos, J., Pereira, D., Santana, M. M., Cavadas, C., & de Almeida, L. P. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_18 · Cited by 28
Self-citationNeurodegenerative diseases: model organisms, pathology and autophagy
Suresh, S., Verma, V., Sateesh, S., Clement, J. P., & Manjithaya, R. R. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0955-3 · Cited by 23
Multifaced role of protein deacetylase sirtuins in neurodegenerative disease.
Gupta, R., Ambasta, R. K., & Kumar, P. (2021) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.047 · Cited by 18
Yao, M., Zhao, Z., Wei, L., Zhou, D., Xue, Z., & Ge, S. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.02.011 · Cited by 22
Seranova, E., Palhegyi, A. M., Verma, S., Dimova, S., Lasry, R., Naama, M., Sun, C., Barrett, T. G., Rosenstock, T. R., Kumar, D., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.024 · Cited by 23
Recent therapeutic prospects for Machado–Joseph disease
Costa, M. D. C. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000832 · Cited by 21
“Numerous approaches to enhancing cellular homeostasis have shown positive outcomes in MJD/SCA3 mouse trials: caloric restriction [80];”
BackgroundZarini, D., Pasbakhsh, P., Nekoonam, S., Mojaverrostami, S., Ghasemi, S., Shabani, M., & Kashani, I. R. (2021) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2021.102013 · Cited by 20
Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease
Miranda, C. O., Nobre, R. J., Paiva, V. H., Duarte, J. V., Castelhano, J., Petrella, L., Sereno, J., Santana, M. M., Afonso, S., Januário, C., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01329-4 · Cited by 20
SIRT2 Deficiency Exacerbates Hepatic Steatosis via a Putative Role of the ER Stress Pathway
Leal, H., Cardoso, J. A., Valério, P., Quatorze, M., Carmona, V., Cunha‐Santos, J., de Almeida, L. P., Pereira, C. M., Cavadas, C., & Gomes, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126790 · Cited by 18
“Lentiviral transduction of HepG2 cells was performed as previously described [48].”
MethodSelf-citationHereditary Ataxias: From Bench to Clinic, Where Do We Stand?
Pilotto, F., Bondio, A. D., & Puccio, H. M. (2024) · Cells · doi:10.3390/cells13040319 · Cited by 28
Onikanni, S. A., Lawal, B., Oyinloye, B. E., Ajiboye, B. O., Sukhbat, U., Wang, C., Emran, T. B., & Simal‐Gándara, J. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121247 · Cited by 19
Watchon, M., Luu, L., Robinson, K. J., Yuan, K. C., Luca, A. D., Suddull, H. J., Tym, M. C., Guillemin, G. J., Cole, N. J., Nicholson, G. A., et al. (2021) · Molecular Brain · doi:10.1186/s13041-021-00839-x · Cited by 17
Functional relevance of miRNAs in premature ageing
Caravia, X. M., Roiz‐Valle, D., Morán-Álvarez, A., & López-Otín, C. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.05.003 · Cited by 17
“…acts in a NAD+dependent manner, is essential in caloric restriction, and SIRT1 depletion abrogates its positive effects (Cohen, 2004; Verdin, 2015; Cunha-Santos et al., 2016). miRNAs play essential roles in epigenetic alterations, especially in SIRT1 regulation. miR-217 is upregulated during…”
BackgroundPirmoradi, Z., Nakhaie, M., Ranjbar, H., Kalantar-Neyestanaki, D., Kohlmeier, K. A., Asadi‐Shekaari, M., Hassanshahi, A., & Shabani, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-60518-4 · Cited by 16
Jansen‐West, K. R., Todd, T. W., Daughrity, L. M., Yue, M., Tong, J., Carlomagno, Y., del Rosso, G., Kurti, A., Jones, C. Y., Dunmore, J. A., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.863089 · Cited by 18
“…to assess whether lowering endogenous Atxn3 levels or altering other factors can influence the effects of mutant ATXN3 on the striatum (Simoes et al., 2012; Goncalves et al., 2013; Cunha-Santos et al., 2016; Nobre et al., 2021); we believe future studies using ourmodel will build upon this work.”
BackgroundWatchon, M., Robinson, K. J., Luu, L., An, Y., Yuan, K. C., Plenderleith, S. K., Cheng, F., Don, E. K., Nicholson, G. A., Lee, A., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202300963rr · Cited by 16
Preclinical Assessment of Mesenchymal-Stem-Cell-Based Therapies in Spinocerebellar Ataxia Type 3
Correia, J. S., Neves‐Carvalho, A., Mendes-Pinheiro, B., Pires, J., Teixeira, F. G., Lima, R., Monteiro, S., Silva, N. A., Soares‐Cunha, C., Serra, S. C., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121754 · Cited by 14
Lima, M. C. F., & Raposo, M. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_16 · Cited by 13
Nutritional interventions for spinal cord injury: preclinical efficacy and molecular mechanisms
Campos, J., Silva, N. A., & Salgado, A. J. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab068 · Cited by 15
Polyglutamine spinocerebellar ataxias: emerging therapeutic targets
Neves‐Carvalho, A., Duarte‐Silva, S., Teixeira‐Castro, A., & Maciel, P. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1827394 · Cited by 11
Sena, P. P., Weber, J. J., Watchon, M., Robinson, K. J., Wassouf, Z., Hauser, S., Helm, J., Abeditashi, M., Schmidt, J., Hübener‐Schmid, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025810118 · Cited by 12
Experimental and Clinical Strategies for Treating Spinocerebellar Ataxia Type 3
Wang, Z. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.11.051 · Cited by 11
Raj, K., & Akundi, R. S. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02314-z · Cited by 11
“SIRT1 levels can also be increased through the use of resveratrol, a phytoalexin and a common dietary supplement, which reduces motor deficits in transgenic MJD mice [201].”
BackgroundFurtado, G. V., Yang, J. H., Wu, D., Papagiannopoulos, C. I., Terpstra, H. M., Kuiper, E. F. E., Krauß, S., Zhu, W., Kampinga, H. H., & Bergink, S. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab095 · Cited by 8
Chen, Y.-S., Harn, H., Hong, Z.-X., Huang, Y., Lin, Y.-T., Zheng, H.-X., Chen, P., Yang, H., Chen, P., Tsai, H., et al. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106608 · Cited by 8
Growth hormone rescue cerebellar degeneration in SCA3 transgenic mice.
Wu, S., Liu, K.-H., Cheng, W.-L., Su, S.-L., Lin, Y., Lin, T.-T., Cheng, Y.-S., Chang, J.-C., Wu, Y., & Liu, C. (2020) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2020.05.116 · Cited by 6
Profiling Microglia in a Mouse Model of Machado–Joseph Disease
Campos, A. B., Duarte‐Silva, S., Fernandes, B., das Neves, S. P., Marques, F., Teixeira‐Castro, A., Neves‐Carvalho, A., Monteiro‐Fernandes, D., Portugal, C. C., Socodato, R., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10020237 · Cited by 11
“Although microgliosis has been observed both in MJD patients’ post-mortem brains [23–25] and a mouse model of MJD [26], further studies are required to fully understand the basis of microglial activation in MJD [25].”
BackgroundResultViral-based animal models in polyglutamine disorders
Henriques, C., Lopes, M. M., Silva, A. C., Lobo, D. D., Badin, R. A., Hantraye, P., de Almeida, L. P., & Nobre, R. J. (2024) · Brain · doi:10.1093/brain/awae012 · Cited by 6
Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado–Joseph Disease
Campos, A. B., Duarte‐Silva, S., Fernandes, B., Coimbra, B., Campos, J., Monteiro‐Fernandes, D., Teixeira‐Castro, A., Ambrósio, A. F., & Maciel, P. (2022) · Cells · doi:10.3390/cells11132022 · Cited by 8
“In fact, reactive microgliosis was observed in MJD patients’ brains [9,26,27] and in a mouse model of MJD [28].”
BackgroundMendonça, L. S., Moreira, R., Henriques, D., Zuzarte, M., Ribeiro‐Rodrigues, T., Girão, H., & de Almeida, L. P. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07659-0 · Cited by 6
Circadian rhythms are disrupted in patients and preclinical models of Machado-Joseph disease
Ribeiro, R. F. N., Pereira, D., Lopes, S., Reis, T., Silva, P., Lobo, D. D., Gaspar, L. S., Durães, J., Fernandes, A. R., Ferreira‐Marques, M., et al. (2025) · Brain · doi:10.1093/brain/awaf199 · Cited by 8
“9,10 Furthermore, while sleep problems have been described in MJD, 11-13 the role of circadian rhythms in its pathophysiology remains largely unexplored, both in this condition and other spi-nocerebellar ataxias (SCAs).”
Self-citationDual GSK3β/SIRT1 modulators for Alzheimer’s: mechanisms, drug discovery and future perspectives
Kareem, A. I., Kapp, E., Joubert, J., & Zou, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1662241 · Cited by 6
Santana, M. M., Gaspar, L. S., Pinto, M. M., Silva, P., Adão, D., Pereira, D., Ribeiro, J. A., Cunha, I., Hübener‐Schmid, J., Raposo, M., et al. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12892 · Cited by 5
The central role of mitochondrial dysfunction in neurodegeneration: implications for therapy
Raafat, M. A., Al-Hasnaawei, S., Mousa, H. M., Hanumanthayya, M., Sahoo, S., Prathiba, S., Singh, G., & Sinha, A. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05542-w · Cited by 6
Adults up to 80 years old maintain effective movement planning when facing complex body dynamics
Matthijs, A., de Witte, A., Mantini, D., & de Xivry, J. O. (2025) · GeroScience · doi:10.1007/s11357-025-02051-4 · Cited by 9
Jia, C.-J., Chen, M.-N., Huang, D.-D., Wu, S.-F., Zeng, C.-M., Liu, Z., Wang, M.-X., Huang, Y.-F., Yuan, Q.-J., & Zhang, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113686 · Cited by 4
Henriques, C., Silva, M., da Silva, A. A., Rufino‐Ramos, D., Lopes, M. M., Badin, R. A., Hantraye, P., de Almeida, L. P., & Nobre, R. J. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115413 · Cited by 3
“…al., 2008; Alves et al., 2010; Sim ˜ oes et al., 2012; Gonçalves et al., 2013; N ´ obrega et al., 2013; Sim ˜ oes et al., 2014; Conceiç ˜ ao et al., 2016; Cunha-Santos et al., 2016; Carmona et al., 2017; Mendonça et al., 2019; Santana et al., 2020; Sim ˜ oes et al., 2022; Nobre et al., 2022;…”
Pekary, A. E., & Sattin, A. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.356 · Cited by 2
Ding, D., Chen, Z., Wang, C., Tang, X., Zhang, L., Fang, Q., Qiu, R., & Jiang, H. F. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.822657 · Cited by 2
Xu, M., Li, T., Liu, X., Islam, B., Xiang, Y., Zou, X., & Wang, J. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04311-9 · Cited by 3
A systematic screening assay identifies efficient small guide RNAs for CRISPR activation
Arvidsson, E., Lobo, D. D., Sabarese, E., Duarte, F. T., Nobre, R. J., Lundberg, C., & Quintino, L. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1336313 · Cited by 3
Deng, Q., Tang, C., Chen, Z., Yuan, X., Ding, Z., Wang, C., Wan, L., Hu, J. M., Deng, F., Long, Z., et al. (2025) · Movement Disorders · doi:10.1002/mds.30189 · Cited by 2
Neurodegenerative Diseases and Autophagy
Fleming, A., Vicinanza, M., Renna, M., Puri, C., Ricketts, T., Füllgrabe, J., López, A., de Jager, S., Ashkenazi, A., Tanasa, M. P., et al. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00011-0 · Cited by 4
“, 2008), and lower levels of Sirtuin-1 are observed in SCA3 mouse model (Cunha-Santos et al., 2016).”
BackgroundGene expression changes in cerebellum induced by dietary restriction
Sant, L. J. V., Birkisdóttir, M. B., Ozinga, R. A., Gyenis, Á., Hoeijmakers, J. H. J., Vermeij, W. P., & Jaarsma, D. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1185665 · Cited by 3
“, 2020; Wahl and LaRocca, 2021), and can be mechanistically linked to the neuroprotective effect of DR in cerebellar neurodegeneration mouse models (Cunha-Santos et al., 2016; Birkisdottir et al., 2021; Birkisdóttir et al., 2023).”
BackgroundMesenchymal stem cells for lysosomal storage and polyglutamine disorders: Possible shared mechanisms
Miranda, C. O. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13707 · Cited by 4
Nuclear aging in polyglutamine-induced neurodegeneration
Pereira, D., Cunha‐Santos, J., Vasconcelos‐Ferreira, A., Duarte‐Neves, J., Onofre, I., Aveleira, C. A., Carmona, V., Cortes, L., Lopes, S. M., Lobo, D. D., et al. (2026) · npj Aging · doi:10.1038/s41514-026-00469-4 · Cited by 1
Self-citationChen, Y.-S., Harn, H., Hong, Z.-X., Huang, Y., Lin, Y.-T., Zheng, H.-X., Chen, P., Yang, H., Chen, P., Tsai, H., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-820726/v1 · Cited by 1
“The downregulated autophagy has been measured in SCA3 patients 245 [25, 26, 30].”
BackgroundPre-Clinical Assessment of Mesenchymal Stem Cell-Based Therapies in Spinocerebellar Ataxia Type 3Preprint
Neves-Carvalho, A., Mendes-Pinheiro, B., Correia, J. S., Pires, J., Teixeira, F. G., Silva, N., Lima, R., Monteiro, S., Duarte‐Silva, S., Salgado, A. J., et al. (2019) · SSRN Electronic Journal · doi:10.2139/ssrn.3475576
Mitochondrial dysfunction and autophagy in neurodegeneration
Gupta, R. V., Ambasta, R. K., & Kumar, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00019-x
Stévanin, G., Alves, S., & Dürr, A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.23362-2
Blood and CSF Biomarkers in Autosomal Dominant Cerebellar Ataxias
Coarelli, G., & Dürr, A. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24345-5_13
Spinocerebellar Ataxia Type 7: From Mechanistic Pathways to Therapeutic Opportunities
Switonski, P. M., & Spada, A. R. L. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-24345-5_17
32nd Annual GP2A Medicinal Chemistry Conference
Hélesbeux, J., McCarthy, F. O., Silva, M. M., Leitão, A. J., Burke, A. J., Salvador, J. A. R., Moreira, R., Sousa, E., Moreira, V. M., & Marchand, P. (2025) · Drugs and Drug Candidates · doi:10.3390/ddc4010002
Henriques, C., Lobo, D. D., da Silva, A. C., Fernandes, A. R., Lopes, M. M., Fayard, A., Jan, C., Lecourtois, S., Guillermier, M., Flament, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.02.680027 · Cited by 1
Metadata
- Authors
- Cunha-Santos, J., Duarte-Neves, J., Carmona, V., Guarente, L., Pereira de Almeida, L., & Cavadas, C.
- Affiliations
- Koch Institute for Integrative Cancer Research At MIT (US)
- University of Coimbra (PT)
- Corresponding author
- Cavadas, Cláudia
- Venue
- Nature Communications
- Published
- 2016-05-11
- Volume
- 7
- Issue
- 1
- Pages
- 11445-11445
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4865854
- OpenAlex
- W2367767229
- Cited by
- 109
- References
- 51
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 8 · 2023: 8 · 2022: 8 · 2021: 18 · 2020: 10 · 2019: 10 · 2018: 16 · 2017: 10 · 2016: 3
- FWCI
- 7.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Estudo Geral (Universidade de Coimbra) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Nature
- Funders
- National Ataxia Foundation
- Muscular Dystrophy Association
- E-Rare
- Fundação para a Ciência e a Tecnologia (04539, COMPETE, CENTRO-07-ST24-FEDER-002002, UID/NEU/04539/2013, E-Rare4/0003/2012, SFRH/BD/74993/2010, SFRH/BD/87404/2012)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- spinocerebellar ataxia type 3, caloric restriction, SIRT1, ataxin-3, polyglutamine expansion, motor incoordination, neuropathology, neuroinflammation, autophagy, resveratrol, gene delivery, neurodegeneration
- MeSH terms
- Ataxin-3, Resveratrol, Animals, Autophagy, Cerebellum, Disease Models, Animal, Gait, Inflammation, Mice, Inbred C57BL, Mice, Transgenic, Motor Activity, Nervous System, Neurons, RNA, Messenger, Stilbenes, Machado-Joseph Disease, Caloric Restriction, Cell Line, Tumor, Mutant Proteins, Sirtuin 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.